United States - English - NLM (National Library of Medicine)

major pharmaceuticals - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. zafirlukast is contraindicated in patients with hepatic impairment including hepatic cirrhosis.

United States - English - NLM (National Library of Medicine)

strides pharma science limited - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. zafirlukast is contraindicated in patients with hepatic impairment including hepatic cirrhosis.

United States - English - NLM (National Library of Medicine)

avkare - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. zafirlukast is contraindicated in patients with hepatic impairment including hepatic cirrhosis.

United States - English - NLM (National Library of Medicine)

avera mckennan hospital - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast 20 mg

United States - English - NLM (National Library of Medicine)

state of florida doh central pharmacy - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast 20 mg - accolate is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. accolate is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - zafirlukast - oral tablet - 20mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - zafirlukast - oral tablet - 20mg

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - zafirlukast 20mg;  ;   - tablet - 20 mg - active: zafirlukast 20mg     excipient: croscarmellose sodium hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose povidone purified water   titanium dioxide

United States - English - NLM (National Library of Medicine)

camber pharmaceuticals, inc. - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. zafirlukast is contraindicated in patients with hepatic impairment including hepatic cirrhosis.

United States - English - NLM (National Library of Medicine)

aurobindo pharma limited - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast tablets are indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. zafirlukast tablets are contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. zafirlukast tablets are contraindicated in patients with hepatic impairment including hepatic cirrhosis.